Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
29.73
+0.29 (0.99%)
At close: Mar 9, 2026, 4:00 PM EDT
29.73
0.00 (0.00%)
After-hours: Mar 9, 2026, 6:00 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.78 billion as of March 9, 2026. Its market cap has increased by 69.48% in one year.
Market Cap
1.78B
Enterprise Value
1.32B
1-Year Change
69.48%
Ranking
Category
Stock Price
$29.73
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.78B, an increase of 82.53%. That is a compound annual growth rate of 21.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.76B | 92.63% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.83B |
| Veradermics | 1.81B |
| Palvella Therapeutics | 1.81B |
| Zymeworks | 1.78B |
| Relay Therapeutics | 1.77B |
| Definium Therapeutics | 1.76B |
| Sarepta Therapeutics | 1.75B |
| Galecto | 1.74B |